MoneyWorks4Me

Ganga Pharmaceuticals informs about certificate

20 Apr 2022 Evaluate

In accordance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, Ganga Pharmaceuticals has informed that it enclosed certificate received from its Registrar and Share Transfer Agent, KFIN Technologies confirming dematerialization of Shares, mutilation & cancellation of Share Certificates received for dematerialization during the quarter ended March 31, 2022.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..